These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3514951)

  • 21. Echographic evaluation of the incrustation of intrauterine contraceptive devices (IUD).
    Patai K; Harkányi Z; Varga P; Berényi M
    Acta Chir Hung; 1988; 29(1):87-93. PubMed ID: 3293337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of intrauterine devices with missing tails during early pregnancy.
    Assaf A; Gohar M; Saad S; el-Nashar A; Abdel Aziz A
    Contraception; 1992 Jun; 45(6):541-6. PubMed ID: 1617963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrauterine contraceptive devices: MR imaging.
    Mark AS; Hricak H
    Radiology; 1987 Feb; 162(2):311-4. PubMed ID: 3797642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper IUDs.
    Thiery M
    Contracept Deliv Syst; 1983 Jul; 4(3):175-85. PubMed ID: 12265360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrauterine contraceptive devices: evaluation by sonography.
    Callen PW; Filly RA; Munyer TP
    AJR Am J Roentgenol; 1980 Oct; 135(4):797-800. PubMed ID: 6778115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of intrauterine devices following uterine perforation.
    Adoni A; Ben Chetrit A
    Contraception; 1991 Jan; 43(1):77-81. PubMed ID: 1825971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
    Pizarro E; Gomez-Rogers C; Rowe PJ
    Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ultrasound localization of intrauterine contraceptive devices in the laboratory and in patients (author's transl)].
    Schmidt EH; Quakernack K; Lieder B; Beller FK
    Arch Gynakol; 1975 Jul; 218(3):173-81. PubMed ID: 1174304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.